Michael J.M. Hitchcock insider trades: Biomea Fusion (BMEA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | BMEA | ↑ Buy | 100,000 | $0.99 | $99K | Direct | Dec 4, 2025 (2d) |
| Sep 30, 2024 | BMEA | ↑ Buy | 10,000 | $10.06 | $101K | Direct | Oct 1, 2024 (1d) |
| Nov 14, 2022 | BMEA | ↑ Buy | 5,000 | $7.93 | $40K | Direct | Nov 16, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMEA insiders
Open-market trades in the last 12 months
About Michael J.M. Hitchcock's insider trades
Michael J.M. Hitchcock is Interim CEO at Biomea Fusion (BMEA). Since Nov 14, 2022, Michael has reported 3 open-market purchases worth $239K and no sales on SEC Form 4. In the last 12 months: 1 buy ($99K).
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMEA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.